Neil Gregory Almstead - Jan 7, 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Chief Technical Ops Officer
Signature
/s/ Avraham S. Adler, attorney-in-fact
Stock symbol
PTCT
Transactions as of
Jan 7, 2022
Transactions value $
-$30,859
Form type
4
Date filed
1/11/2022, 03:20 PM
Previous filing
Jan 6, 2022
Next filing
Jan 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$29.1K -756 -2.11% $38.53 35.1K Jan 7, 2022 Direct F1
transaction PTCT Common Stock Award $0 +14.4K +41.07% $0.00 49.5K Jan 7, 2022 Direct F2
transaction PTCT Common Stock Sale -$1.73K -45 -2.56% $38.53 1.71K Jan 7, 2022 By Spouse F3
transaction PTCT Common Stock Award $0 +780 +45.61% $0.00 2.49K Jan 7, 2022 By Spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +54K $0.00 54K Jan 7, 2022 Common Stock 54K $38.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs.
F2 Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
F3 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs.
F4 This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.